About
Renovorx Inc (NASDAQ:RNXT) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting
Apr 14 2026
Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting
Apr 8 2026
RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum
Apr 1 2026
RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
Mar 30 2026
RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update
Financials
Revenue
$1.12 M
Market Cap
$46.34 M
EPS
-0.32
Translate